Intermediate dose recombinant interferon-alpha as second-line treatment for patients with recurrent cutaneous melanoma who were pretreated with low dose interferon / Ascierto, P; Daponte, A; Parasole, R; Perrone, F; Caraco, C; Melucci, Mt; Palmieri, G; Napolitano, M; Mozzillo, N; Castello, G. - In: CANCER. - ISSN 0008-543X. - 89:7(2000), pp. 1490-1494. [10.1002/1097-0142(20001001)89:7<1490::AID-CNCR11>3.0.CO;2-V]

Intermediate dose recombinant interferon-alpha as second-line treatment for patients with recurrent cutaneous melanoma who were pretreated with low dose interferon

Ascierto P;
2000

2000
Intermediate dose recombinant interferon-alpha as second-line treatment for patients with recurrent cutaneous melanoma who were pretreated with low dose interferon / Ascierto, P; Daponte, A; Parasole, R; Perrone, F; Caraco, C; Melucci, Mt; Palmieri, G; Napolitano, M; Mozzillo, N; Castello, G. - In: CANCER. - ISSN 0008-543X. - 89:7(2000), pp. 1490-1494. [10.1002/1097-0142(20001001)89:7<1490::AID-CNCR11>3.0.CO;2-V]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1014114
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact